GENEVA, July 18 -- I2O THERAPEUTICS, INC. filed a patent application (US2026/011104) for “INJECTABLE FORMULATIONS COMPRISING THERAPEUTIC COMPOUNDS AND METHODS OF USING THEREOF”. With publication no. WO/2026/152138, here are the other details related to the patent application:
Kind: Initial Publication without ISR [A2]
IPC: A61K 9/16
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....